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Cellular delivery and photochemical release of a
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Inositol pyrophosphates, such as diphospho-myo-inositol pentakisphosphates (InsP7), are an
important family of signalling molecules, implicated in many cellular processes and
therapeutic indications including insulin secretion, glucose homeostasis and weight gain.
To understand their cellular functions, chemical tools such as photocaged analogues for their
real-time modulation in cells are required. Here we describe a concise, modular synthesis of
InsP7 and caged InsP7. The caged molecule is stable and releases InsP7 only on irradiation.
While photocaged InsP7 does not enter cells, its cellular uptake is achieved using
nanoparticles formed by association with a guanidinium-rich molecular transporter. This
novel synthesis and unprecedented polyphosphate delivery strategy enable the ﬁrst studies
required to understand InsP7 signalling in cells with controlled spatiotemporal resolution.
It is shown herein that cytoplasmic photouncaging of InsP7 leads to translocation of the
PH-domain of Akt, an important signalling-node kinase involved in glucose homeostasis, from
the membrane into the cytoplasm.
DOI: 10.1038/ncomms10622 OPEN
1 Department of Chemistry, University of Zurich, Winterthurerstrasse 190, Zurich 8057, Switzerland. 2 Departments of Chemistry and Chemical and Systems
Biology, Stanford University, Stanford, California 94305, USA. 3 European Molecular Biology Laboratory (EMBL), Cell Biology & Biophysics Unit,
Meyerhofstrasse 1, 69117 Heidelberg, Germany. 4Departamento de Quı´mica Orga´nica, Facultad de Ciencias, Universidad de Ma´laga, Malaga 29071, Spain.
5 Department of Chemistry and Pharmacy, Albert-Ludwigs University Freiburg, Albertstrasse 21, 79104 Freiburg, Germany. Correspondence and requests for
materials should be addressed to P.A.W. (email: Wenderp@stanford.edu) or to H.J.J. (email: henning.jessen@oc.uni-freiburg.de).
NATURE COMMUNICATIONS | 7:10622 | DOI: 10.1038/ncomms10622 | www.nature.com/naturecommunications 1
D
iphospho-inositol polyphosphates (InsP7) are second
messengers involved in essential cell signalling
pathways1–4. A distinct difference of InsP7 compared
with other inositol polyphosphates is the presence of a
phosphoanhydride bond in, for example, the 5-position
(5-InsP7, Fig. 1), rendering them a structurally unique class of
second messengers. This special feature is also the reason for their
nickname ‘inositol pyrophosphates’. InsP7 are implicated in the
regulation of diverse cellular and metabolic functions in different
kingdoms of life1–8. It has been proposed that InsP7 bind to the
pleckstrin homology (PH) domain of protein kinase B (Akt),
and competitively suppress its speciﬁc phosphatidylinositol
3,4,5-trisphosphate (PIP3) association at the plasma membrane,
thereby inhibiting phosphoinositide-dependent kinase 1
(PDK1)-mediated phosphorylation of Akt9,10. However, there
remains uncertainty as to whether the reduced phosphorylation
of Akt is a result of the inhibition of its membrane association via
its PH-domain, since the in vitro assays that have been performed
do not contain any membrane or membrane mimics. In addition,
InsP7 might act either as allosteric inhibitors or as non-enzymatic
phosphorylating agents or both3,11. Notwithstanding, inhibition
of the Akt pathway by InsP7 has an impact on glucose uptake and
insulin sensitivity, as exempliﬁed by a mouse model that lacks
inositol hexakisphosphate-kinase 1 (IP6K1). These knockout
mice have reduced levels of InsP7 and show a lean phenotype on
high-fat diet concomitant with increased insulin sensitivity9.
As a consequence, IP6K1 has recently been proposed as a novel
target in the treatment of diabetes and obesity12. To address
fundamental questions about the mechanism of action of these
potent signalling molecules and their subcellular localization, the
development of new chemical tools is required.
To understand cellular signalling mediated by second
messengers, photocaged analogues that can be activated on
demand inside living cells with spatiotemporal resolution
have attracted great interest13. Unfortunately, preparation
of such analogues often requires lengthy synthetic sequences.
Phosphorylated second messengers derived from myo-inositol
such as myo-inositol 1,4,5-trisphosphate (Fig. 1) present
additional challenges as their polyanionic nature precludes
efﬁcient cellular uptake14. For example, while cell-permeable
and photocaged analogues of different myo-inositol polyphos-
phates (InsPx) and phosphatidyl myo-inositol polyphosphates
(PtdIns-Px) have been reported15–18, the phosphate groups
typically need to be reversibly masked. This complicates their
use, as multiple intracellular hydrolysis events must occur before
the free polyphosphate is formed19. Even so, no such photocaged
derivatives are currently available for the more complex
diphospho-myo-inositol pentakisphosphates as, for example,
5-InsP7 (Fig. 1)20.
Here we report the design, step-economical synthesis,
photophysical and metabolic evaluation of photocaged 5-InsP7,
and signiﬁcantly, a general solution to the delivery of unmodiﬁed
polyphosphate probes into cells using guanidinium-rich mole-
cular transporters21. On cytoplasmic uncaging, 5-InsP7-mediated
PH-domain translocation from the membrane into the cytosol in
living cells is demonstrated for the ﬁrst time on a 15-min
timescale.
Results
Synthesis. All current synthetic approaches to access any InsP7
isomer rely on a global hydrogenation in the last step, during
which up to 13 protecting groups need to be removed22–30.
Signiﬁcantly, however, hydrogenation is incompatible with
photocaging groups and many other functional moieties like,
for example, ﬂuorophores. To address this problem, a novel
strategy based on the development of a levulinate benzyl ester
adaptor (LevB) is described. The introduction of this new
protecting group and its combination with ﬂuorenylmethyl
(Fm) protection31–33 and photocage introduction enables
the previously inaccessible synthesis of the ﬁrst photoactivatable
diphospho-inositol InsP7 probe 9 equipped with a
[7-(diethylamino)-coumarin-4-yl]methyl (DEACM) photocage
(Fig. 2a). It is noteworthy that this strategy potentially
facilitates the introduction of other tags, such as, for example,
photoafﬁnity labels and ﬂuorophores.
The synthesis commenced with benzylidene protected 2
prepared as previously described (Fig. 2a)23. The 5-OH position
of 2 is available for phosphitylation, allowing virtually any
protected phosphate to be introduced. However, none of the
existing protecting groups are compatible with the subsequent
introduction of the coumarin cage. Such protecting groups would
need to be stable under acidic and basic conditions and must
enable double deprotection under very mild conditions. To meet
these stringent requirements, a new phosphate-protecting group
is required. The approach described herein is based on an
Umpolung strategy that had been exploited in prodrug design for
nucleotides34,35. Conceptually, this strategy is useful to generally
couple phenol or alcohol protecting groups to phosphates via a
benzyl adaptor, greatly enhancing the available protecting group
strategies for phosphates (Fig. 2b). A novel P-amidite 3 was
developed (Fig. 2, Supplementary Fig. 1), which is connected via a
benzyl ester to a levulinate group (LevB). After oxidation to the
phosphate triester 6, the LevB group can be cleaved by hydrazone
formation, initiating cyclization and ﬁnally a Grob-type
fragmentation to give the unprotected phosphates (Fig. 2b).
After coupling P-amidite 3 to alcohol 2 and oxidation, all
inositol-protecting groups were cleaved with TFA. The resultant
protected monophosphate 4 was phosphitylated with (Fm)2-P-
amidite 5 and oxidized. Notwithstanding the signiﬁcant
molecular crowding of hexakisphosphate 6, both LevB groups
were efﬁciently cleaved under mild conditions (hydrazine*AcOH/
TFA), releasing phosphate 7. Next, the P-anhydride was formed
using Fm-protected photocaged P-amidite 8 (ref. 33). All 11
Fm-protecting groups were then cleaved with piperidine resulting
in highly pure photocaged 5-InsP7 9 in 45% yield over 2 steps
(11% overall yield from 1) on precipitation of the compound as
the dodeca-piperidinium salt. The piperidinium ions can also be
exchanged with sodium ions by precipitation. In addition, natural
5-InsP7 10 can be prepared following the same strategy by using
(Fm)2-P-amidite 5 in the anhydride forming reaction (8% overall
yield from 1)36,37. This eight-step synthesis represents a general
strategy to access 5-InsP7 10 and caged analogues in scalable
amounts (30mg of 9 have been prepared) and very high quality
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Figure 1 | Phosphorylated second messengers derived from myo-inositol.
Chemical structures of myo-Inositol 1,4,5-trisphosphate and 5-diphospho-
myo-inositol pentakisphosphate (5-InsP7).
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without the need for a ﬁnal hydrogenation under aqueous
conditions.
In vitro stability and photophysical properties. To serve as a
useful tool, DEACM 5–InsP7 9 must be stable towards enzymatic
digestion to enable cellular uptake and release only on photolysis.
To test its stability, 9 was incubated in tissue homogenate (brain,
Fig. 3a; liver, Supplementary Fig. 3 and Supplementary Methods)
and cell extract (Supplementary Figs 4–5 and Supplementary
Methods). Readout was achieved by resolution on polyacrylamide
gels (35%, Fig. 3 and Supplementary Methods)38. DEACM
5–InsP7 9 did not decompose under these conditions over
incubation times up to 5 h (Fig. 3a, Lanes III–V and
Supplementary Figs 3–5). Thus, 9 is a probe that has the
potential to be broadly applied in different cell and tissue types.
Importantly, on exposure to ultraviolet light (366 nm, 4W,
distance 10 cm) in extracts, it was cleanly converted into 5-InsP7
10, as veriﬁed by PAGE (Fig. 3a, Lanes VI and VII and
Supplementary Figs 3–4) and HPLC analysis (Supplementary
Fig. 6) with 10 as a standard.
Next, the photophysical properties of DEACM 5–InsP7 9 were
characterized. The quantum yield for the disappearance of 9
Djchem is 0.71% at 355 nm as determined by actinometry
following a novel protocol (Supplementary Methods)39–41. The
ﬂuorescence quantum yield jf is 6.2% and the lifetime tf is 1.2 ns.
Notably, 9 also exhibits typical coumarin ﬂuorescence at 500 nm
(excitation at 386 nm; Supplementary Figs 7–10 and Supplemen-
tary Methods)33,42.
Cellular delivery and uncaging. Notwithstanding the efﬁciency
of this synthesis, it was found as expected that DEACM 5–InsP7
9, like other polyanions11,14, does not readily cross the non-polar
membrane of a cell (Fig. 4b,c). To address this problem,
its non-covalent complexation, cell uptake and release using
guanidinium-rich molecular transporters were studied43. 9 was
mixed with amphipathic, guanidinium-rich transporter 11
(Fig. 4a), in an equimolar ratio to form nanoparticles. HeLa
cells were treated with these complexes and analysed for
coumarin ﬂuorescence by ﬂow cytometry. Signiﬁcantly, while
DEACM 5–InsP7 9 itself does not appreciably enter cells, the
transporter-complexed 9 does, as demonstrated by a 10-fold
increase in intracellular ﬂuorescence (Fig. 4b). According to ﬂow
cytometry analysis, over 99% of cells display increased levels of 9
following treatment with the transporter/DEACM–InsP7 complex
(Fig. 4c). It is important to note that other transfection reagents
like Lipofectamine 2000 do not efﬁciently deliver 9 into cells
(Fig. 4b).
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Figure 2 | Synthesis of photocaged 5-InsP7 and mechanism of LevB cleavage. (a) Synthesis of DEACM 5–InsP7 9 and 5-InsP7 10 based on
ﬂuorenylmethyl (Fm) protection and a novel phosphate-protecting group (LevB). DCI, 4,5-dicyanoimidazole; DEACM, [7-(diethylamino)-coumarin-4-
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triggers levulinate (red) cleavage and 1,6-elimination (blue) to release free phosphate. Generally, levulinate could also be replaced with other phenol
protecting groups.
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Delivery and intracellular distribution of 9 were further
analysed in HeLa cells by confocal microscopy after 4 and 16 h
(Fig. 5). The z-stack analysis shows DEACM 5–InsP7 9
distributed throughout the cytoplasm at both time points
(Fig. 5, single z-slice shown). Both diffuse ﬂuorescence and
ﬂuorescent puncta are observed, consistent with mixed diffusion
or endosomal uptake and release44–46. This is additionally
supported by a 65% reduction in cellular uptake when cells
were treated at 4 C, a condition known to inhibit most
endocytotic processes (Supplementary Fig. 11).
Cellular uptake, stability and efﬁcient uncaging in living cells
was additionally veriﬁed by extraction of diphospho-inositol
polyphosphates and other cellular phosphates based on a recently
published TiO2 microsphere enrichment method47. Here it is
shown that this method can also be used to extract analogues
such as 9 from complex cell and tissue lysates (Fig. 3b and
Supplementary Methods) enabling studies concerning its
intracellular fate after delivery. After incubation of DEACM
5–InsP7 9 with HeLa cells in the presence or absence of MoTr 11
and repeated washings to remove external 9, the extracts prepared
from those cells (1 million cells) clearly showed a distinct novel
band corresponding to 9 in the PAGE analysis after enrichment
with TiO2 and elution (Fig. 3b, lanes VI–VII), whereas no such
uptake could be detected in the control experiment without
transporter (Fig. 3b, lane V). To verify its identity, the band
corresponding to DEACM 5–InsP7 9 was extracted from the gel
and analysed by MALDI mass spectrometry, demonstrating its
intracellular stability (Supplementary Fig. 12 and Supplementary
Methods) for multiple hours. Moreover, efﬁcient intracellular
uncaging by irradiation at 366 nm was proven using the same
extraction and resolution method (TiO2 enrichment, then PAGE)
in combination with mass spectrometry after extraction of Lane
VIII (Fig. 3b). These conditions were found to be of no immediate
toxicity (Supplementary Fig. 13 and Supplementary Methods). In
summary, the photocaged molecule 9 is efﬁciently taken up by
cells in the presence of MoTr 11, evenly distributed throughout
the cytoplasm, stable for multiple hours in its caged form and can
be selectively uncaged to 5-InsP7 10, thus fulﬁlling the stringent
requirements imposed on an intracellular signalling probe.
PH-domain translocation. To determine the suitability of the
combined delivery and uncaging strategy for a deeper under-
standing of the effect of InsP7 ﬂuctuations, PH-domain translo-
cation on cytoplasmic InsP7 release was studied. The rationale for
this experiment is provided by the lean phenotype displayed by
IP6K1 knockout mice on high-fat diet and the observation that
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InsP7 inhibit Akt phosphorylation in vitro and in vivo by binding
to the PH-domain9. Collectively, these ﬁndings suggest an effect
of 5-InsP7 on membrane localization of Akt. However, no tool to
augment any InsP7 within seconds in living cells was previously
available. With the new tools in hand, HeLa cells were transiently
transfected with a plasmid expressing the PH-domain of Akt
fused to an enhanced green ﬂuorescent reporter protein
(eGFP)48,49. Cells were serum-starved to induce cytoplasmic
localization of the PH-domain due to absence of growth factors
and therefore inactivation of the PI3K/Akt/mTOR pathway50.
PH–eGFP plasma membrane association was then efﬁciently
induced within 10min on external addition of a combination of
growth factors (insulin-like growth factor (IGF); endothelial
growth factor (EGF)) into the medium. During the starvation
period, cells were loaded with caged InsP7 9/MoTr 11
nanoparticles for 4 h. This treatment alone had no effect on
PH-domain localization. Next, cells were irradiated under a
confocal laser-scanning microscope with short laser pulses
(375 nm, 10MHz, 30 s) in different areas (Fig. 6 dotted circle,
and Supplementary Figs 14–23), and PH-domain localization was
traced using the green channel. After photouncaging, a delayed
but complete PH-domain translocation from the plasma
membrane into the cytoplasm was observed, and these results
were repeated several times (n¼ 4). Signiﬁcantly, translocation
did not occur when cells were incubated with photocaged InsP7 9
or MoTr 11 only (Supplementary Figs 18–23). In these cases, the
PH-domains remained localized on the membrane for several
hours, demonstrating the need for the presence of all components
and ruling out photobleaching of eGFP in the irradiated areas. A
detailed analysis of additional micrographs in pseudo-colour with
ratiometric changes is shown in the Supplementary Information
(Supplementary Figs 14–23). This is the ﬁrst example of
controlled 5-InsP7 10 augmentation inside of a living cell
within a few seconds timeframe coupled to a microscopic
readout on the single cell level. We posit that this strategy will
be useful to understand InsP7 signalling in more detail as
previously possible, as evidenced by the delayed PH-domain
translocation observed for the ﬁrst time in our experiments.
Discussion
This study provides a new strategy to synthesize InsP7 that
enables introduction of caging subunits. The potential utility of
4 h
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Bright field DEACM-InsP7 Merge
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Figure 5 | The molecular transporter 11 delivers photocaged 5-InsP79 into the cytoplasm. Confocal microscopy analysis of HeLa cells incubated
with 5 mM DEACM–InsP7 9 in the presence or absence of transporter 11 after 4 and 16 h of incubation. Efﬁcient uptake of 9 is demonstrated by blue
coumarin ﬂuorescence emitted from the compound. Cells treated with (a) 9 alone for 4 h, (b) 9þ 11 for 4 h, (c) 9 alone for 16 h and (d) 9þ 11 for 16 h.
Scale bars, 35mm.
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photocaged 5-InsP7 9 was demonstrated by photon-triggered
uncaging in rat brain homogenate and other cell extracts. A
complex of 9 with molecular transporter 11 was then shown to
efﬁciently enter cells after non-covalent nanoparticle assembly.
Collectively, these results provide the ﬁrst example of the
synthesis of a photocaged analogue of InsP7 and of its subsequent
delivery into cells using non-covalent complexation with a
guanidinium-rich molecular transporter. A recently developed
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Figure 6 | PH-domain translocation in irradiated and control cells. Confocal ﬂuorescence microscopy analysis of PH–eGFP translocation in HeLa Kyoto
cells after photouncaging in deﬁned areas (dotted circle). (A) Serum-starved cells were loaded with 5 mM 9þ 11 for 4 h and then stimulated with IGF and
EGF (100 ngml 1). Robust recruitment of the PH-domain to the membrane is observed. Photouncaging in the dotted area (white circle) is achieved by
short ultraviolet laser pulses and the change of ﬂuorescence intensity followed over time (0, 5 and 15min). (B) Development of the ﬂuorescence intensity
(indicated as gray value) over time (0, 5, 15min) in three different membrane sections (a, b, c; distance in mm). Photouncaging leads to translocation of the
PH–eGFP construct into the cytoplasm after 5min from the membrane of the irradiated cell. After 15min, complete translocation of the PH-domain into the
cytoplasm is observed (B, b and c), whereas in the non-irradiated control cell the PH–eGFP construct remains localized on the membrane (B, a). Images are
presented in pseudo-colour, normalized over time. Intensities were acquired pre-saturated, with the entire dynamic range of intensity available. Scale bars,
5 mM.
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TiO2 microsphere enrichment method was applied to study the
in cellulo stability of 5-InsP7 analogues and their efﬁcient
photochemical release in combination with MALDI mass
spectrometry. We expect that this combined synthesis, delivery
and analytical strategy will ﬁnd widespread and general
application in cell signalling studies as a convenient way to
rapidly augment 5-InsP7 10 with spatiotemporal resolution.
Along these lines, it was shown that cytoplasmic release of
5-InsP7 triggers delayed but complete membrane desorption of
the PH-domain of Akt within 15min. In the human proteome,
PH-domains are the 11th most common domain51, and the new
approach described in this publication will enable a systematic
understanding of the effect of inositol-pyrophosphate
augmentation on protein localization.
Methods
Experimental data of synthetic compounds. For 1H, 13C and 31P NMR
spectra of compounds and MALDI and HR-ESI MS spectra see Supplementary
Figs 24–70. 1H NMR spectra were recorded on Bruker 400MHz spectrometers or
Bruker 500MHz spectrometers (equipped with a cryo platform) at 298K in the
indicated deuterated solvent. 31P[1H]-NMR spectra and 31P NMR spectra were
recorded with 1H-decoupling or 1H coupling on Bruker 162MHz or Bruker
202MHz spectrometers (equipped with a cryo platform) at 298 K in the indicated
deuterated solvent. All signals were referenced to an internal standard (PPP).
13C[1H]-NMR spectra were recorded with 1H-decoupling on Bruker 101MHz or
Bruker 125MHz spectrometers (equipped with a cryo platform) at 298K in the
indicated deuterated solvent. All signals were referenced to the internal solvent
signal as standard (CDCl3, d 77.0; CD3OD, d 49.0; DMSO-d6, d 39.5).
Detailed synthetic procedures for all new compounds are provided in the
Supplementary Information (see Supplementary Methods, chemical synthesis).
Cellular uptake by ﬂow cytometry. Caged-IP7 9 and oligomer 11 were brought
up in pH 7.4 PBS buffer at 1mM concentrations. HeLa cells were seeded at
40,000 cells per well in a 24-well plate and allowed to adhere overnight. The
IP7:co-oligomer complexes were formed at a 1:1 molar ratio by mixing 8 ml of
1mM oligomer stock with 8 ml of 1mM caged-IP7 9 stock in 184 ml PBS pH 7.4.
For conditions with caged-IP7 9 alone, 8 ml of 1mM caged-IP7 9 stock was added
to 192ml PBS pH 7.4. The complexes were allowed to incubate for 30min at
room temperature. The Lipofectamine 2000 control was prepared in OptiMEM
according to the manufacturer’s instructions (0.75 ml Lipofectamine into 62.5 ml.
OptiMEM, 8ml caged-IP7 9 stock into 54.5 ml OptiMEM). The cells were washed
with B0.5ml serum-free DMEM medium, then 400 ml serum-free DMEM was
added to wells with untreated cells; 368.75 ml to wells treated with Lipofectamine
2000; 350 ml to treated wells. Then 31.25 ml Lipofectamine:caged-IP7 9 and 50 ml of
the caged-IP7:co-oligomer complexes were added to each respective well for a ﬁnal
caged-IP7 9 concentration of 5 mM; all conditions were performed in triplicate. The
cells were incubated at 37 C for 3 h. The medium was then removed and the cells
were washed with 1.0ml PBS. About 0.4ml EDTA trypsin was added, and the cells
incubated for 8min at 37 C. Next, 0.6ml of serum-containing DMEM medium
was added, and the contents of each well were transferred to a 15ml centrifuge tube
and centrifuged (1,200 r.p.m. for 5min). The cells were collected and re-dispersed
in 200ml PBS, transferred to FACS tubes, and read on a ﬂow cytometry analyser.
Results were analysed using FlowJo software. The data presented are the mean
ﬂuorescent signals from 10,000 cells analysed.
Fluorescence microscopy. Confocal microscopy was conducted on a CLSM SP5
Mid ultraviolet–visible Leica inverted confocal laser-scanning microscope equipped
with a 15W MaiTai DeepSee twophoton laser (Stanford Cell Sciences Imaging
Facility, Award #S10RR02557401 from the National Center for Research
Resources). HeLa cells were incubated in serum-free DMEM with 5 mM 9 or 9þ 11
(equimolar), for 4 or 16 h. After incubation, media was removed and cells washed
3 with 1.0mgml 1 heparin (180Umg 1, Aldrich) solution in PBS, then
imaged in clear serum-free DMEM. Pictures were recorded with a HCX APO
L 20/1.00 water immersion objective and photomultiplier tube detector.
eGFP–Akt-PH-domain translocation. Mammalian cells (HeLa Kyoto) were grown
up to 50–60% conﬂuence (eight wells Lab-Tek Chamber Slide) in 250 ml DMEM
(10% FBS, 10% Pen/Strep, high glucose (4.5 g l 1)) at 37 C, 5% CO2 for 16 h. Cells
were then washed with 250ml PBS followed by a wash with serum-free DMEM
(-FBS, -Pen/Step). About 230ml serum-free DMEM medium were then added to
each well.
Transfection of HELA cells with the eGFP Akt-PH-domain for imaging:
The transfection mixture was prepared for eight wells. About 200 ng DNA
(eGFP–Akt-PH) in 150 ml DMEM (-FBS) were incubated for 10min at room
temperature. Then, 10 ml FuGENE transfecting reagent were added to DNA
containing DMEM (-FBS) medium and incubated for 20min at room temperature.
About 20 ml of the transfection mixture were then added to each well. Cells were
incubated for 6–8 h at 37 C (5% CO2.). After this period, the transfection mixture
was removed by washing the cells with 250 ml PBS and DMEM (-FBS). Cells
were starved by adding 250 ml DMEM (-FBS) and incubated for 14–16 h at 37 C
(5% CO2).
After overnight starvation, the cells were washed with PBS (250 ml) and 230ml
DMEM (-FBS) were added. Afterwards, 20 ml sample mixture (consisting of caged
InsP7:Co-oligomer (D:G7:7) complexes) were added to each well and distributed
equally. The ﬁnal concentration of the complex was 5 mM for each well. Cells were
then incubated at 37 C (5% CO2) for 4 h.
Imaging of Akt-PH translocation. After 4-h incubation with 9 and 11, HeLa cells
were washed with 250 ml (2 ) imaging buffer (115mM NaCl, 1.2mM CaCl2,
1.2mM MgCl2, 1.2mM K2HPO4, 20mM HEPES). About 200 ml imaging buffer
were added to the wells. Translocation of eGFP–Akt-PH to the membrane was
stimulated by adding a mixture of growth factors EGF and IGF (100 ngml 1
each). Translocation was monitored over 10min at 37 C (5% CO2).
Cells that had responded to treatment with the growth factors and that had the
PH-domain localized at the membrane were used in the uncaging experiments by
confocal laser-scanning microscopy. Non-illuminated neighboring cells were used
as controls.
Confocal laser-scanning microscopy. Imaging was performed on an Olympus
IX83 confocal laser-scanning microscope at 37 C in a 5% CO2 high humidity
atmosphere (EMBL incubation box). Imaging was performed using an Olympus
Plan-APON  60 (numerical aperture 1.4, oil) objective. The images were acquired
utilizing a Hamamatsu C9100-50 EM CCD camera. Image acquisition was
performed via FluoView imaging software, version 4.2. The green channel was
imaged using the 488 nm laser line (120mWcm 2) at 3% laser power and a
525/50 emission mirror. The red channel was imaged using the 559 nm laser
(120mWcm 2) at 2.0% laser power and a 643/50 emission ﬁlter. A pulsed
375 nm laser line (10MHz) was applied for uncaging experiments. For uncaging
experiments, circular regions of interest of 4–10 mm diameter were pre-deﬁned.
Pre-activation images were captured for ﬁve frames (5 s per frame), followed by
30 s of activation within the regions of interest. Recovery images were captured for
35min at a frame rate of 5 s per frame.
Image analysis. Image analysis was conducted utilizing Fiji open source image
analysis software tool52. Lookup tables were applied to match the colour within the
recorded image with the wavelengths of detected light. For comparability, the
lookup tables of pre- and postactivated images were set the same weighting.
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